CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
ARICAbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03769519
NCT03769519N/ACompleted

AdheRence to Inhaled Corticosteroids in Asthma

Duke University·interventional·Posted Dec 7, 2018·Updated Dec 17, 2021

In Brief

A clinical study evaluating ARICA for Medication Adherence and Asthma. Completed, enrolled 29 participants across 1 site.

Detailed Summary

It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 7, 2018
Enrollment StartFeb 27, 2020
Primary CompletionAug 19, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.6 years ago

Interventions

ARICAbehavioral

Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.